Establishment of Immunoglobulin Heavy (IGH) Chain Clonality Testing by Next-Generation Sequencing for Routine Characterization of B-Cell and Plasma Cell Neoplasms2021-02-11T23:46:14-08:00March 21st, 2019|Read more
A next-generation sequencing–based assay for minimal residual disease assessment in AML patients with FLT3-ITD mutations2021-02-11T23:49:39-08:00August 25th, 2018|Read more
Simple deep sequencing-based post-remission MRD surveillance predicts clinical relapse in B-ALL2021-02-11T23:54:51-08:00August 22nd, 2018|Read more
Clinical-scale Rapid Autologous BK-virus Specific T Cell Line generation from Kidney Transplant Recipients with Active Viremia for Adoptive Immunotherapy2021-02-12T21:23:31-08:00November 11th, 2017|Read more
Minimal Residual Disease (MRD) Status Following Induction Chemo-Immunotherapy Predicts Progression-Free Survival In Mantle Cell Lymphoma (MCL): CALGB 50403 (Alliance)2021-02-12T00:14:15-08:00August 9th, 2017|Read more